Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

65
IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
65
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

63
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
63
Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

55
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
55
Heart Valves01:16

Heart Valves

6.9K
The human heart is a complex organ with an intricate system of valves that regulate blood flow. There are two main types of valves: atrioventricular (AV) valves and semilunar valves.
The AV valves prevent the backflow of blood from the ventricles to the atria during ventricular contraction. These valves function with the assistance of the chordae tendineae and papillary muscles. When the ventricles are relaxed, the chordae tendineae are slack, allowing blood to flow from the atria into the...
6.9K
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

80
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
80
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

78
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
78

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Intraprocedural Findings and Outcomes of Redo Procedures After Voltage-Guided Ablation of Persistent Atrial Fibrillation.

Journal of clinical medicine·2026
Same author

Characteristics and outcomes of patients with heart failure and reduced left ventricular ejection fraction in relation to sodium-glucose cotransporter-2 inhibitor treatment: real-world data from the multicentre H<sup>2</sup>-registry.

Clinical research in cardiology : official journal of the German Cardiac Society·2026
Same author

Balloon Postdilation After Transcatheter Aortic Valve Implantation (TAVI) Among Self- and Balloon-Expandable Valves: A Systematic Review and Meta-Analysis.

The American journal of cardiology·2025
Same author

Transcatheter aortic valve implantation with the Trilogy valve for symptomatic native aortic regurgitation (ALIGN-AR): a pivotal, multicentre, single-arm, investigational device exemption study.

Lancet (London, England)·2025
Same author

Rationale and design of the TRIC-I-HF-DZHK24 (TRICuspid Intervention in Heart Failure) trial.

European journal of heart failure·2025
Same author

Right Ventricular-Pulmonary Artery Coupling in Tricuspid Regurgitation: Prognostic Value and Impact of Treatment Strategy.

JACC. Cardiovascular interventions·2025
Same journal

Optimizing Utilization and Minimizing Risk: The Next Era of Mechanical Circulatory Support Devices.

Interventional cardiology clinics·2026
Same journal

Foreword.

Interventional cardiology clinics·2026
Same journal

Future Directions in Temporary Mechanical Circulatory Support for Cardiogenic Shock: Novel Devices and Evolving Therapeutic Paradigms.

Interventional cardiology clinics·2026
Same journal

Prevention and Management of Acute Limb Ischemia when Using Temporary Mechanical Circulatory Support Devices.

Interventional cardiology clinics·2026
Same journal

Prevention and Management of Hemolysis when Utilizing Mechanical Circulatory Support.

Interventional cardiology clinics·2026
Same journal

Optimal Large-Bore Vascular Access and Closure for Percutaneous Mechanical Circulatory Support in Cardiogenic Shock.

Interventional cardiology clinics·2026
See all related articles

Related Experiment Video

Updated: Oct 11, 2025

Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model
05:31

Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model

Published on: June 8, 2022

3.0K

Caval Valve Implantation.

Alexander Lauten1, Henryk Dreger2, Michael Laule2

  • 1Helios Klinikum Erfurt GmbH, Erfurt, Thuringia, Germany; Department of Cardiology, Helios Clinic Erfurt, Nordhauser StraBe 74, Erfurt 99089, Germany.

Interventional Cardiology Clinics
|November 28, 2021
PubMed
Summary
This summary is machine-generated.

Transcatheter therapies are advancing for heart valve disease. Caval valve implantation shows promise for treating severe tricuspid regurgitation (TR) based on early positive outcomes.

Keywords:
Caval valve implantationFunctional tricuspid regurgitationRight heart failureTricuspid valve insufficiencyTricuspid valve regurgitation

More Related Videos

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement
14:14

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement

Published on: December 11, 2017

14.2K
Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots
12:17

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots

Published on: May 21, 2017

11.5K

Related Experiment Videos

Last Updated: Oct 11, 2025

Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model
05:31

Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model

Published on: June 8, 2022

3.0K
Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement
14:14

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement

Published on: December 11, 2017

14.2K
Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots
12:17

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots

Published on: May 21, 2017

11.5K

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Cardiac Surgery

Background:

  • Transcatheter therapies have significantly expanded treatment options for various heart valve diseases.
  • While established for aortic, mitral, and pulmonic valves, catheter-based treatments for tricuspid regurgitation (TR) are in nascent stages.
  • Several interventional concepts for TR, including edge-to-edge repair, transcatheter annuloplasty, tricuspid spacer, and caval valves, are under investigation.

Purpose of the Study:

  • To review the pathophysiological basis of tricuspid regurgitation (TR).
  • To examine the current evidence supporting caval valve implantation for TR.
  • To explore the potential role of caval valve implantation in managing severe TR.

Main Methods:

  • Review of existing literature on tricuspid regurgitation pathophysiology.
  • Analysis of early clinical outcomes from compassionate use case series of interventional TR therapies.
  • Focus on procedural feasibility and early results of caval valve implantation.

Main Results:

  • Procedural feasibility has been demonstrated for several interventional TR concepts.
  • Small compassionate case series have shown favorable early clinical outcomes for these novel TR therapies.
  • Early data suggests potential efficacy for caval valve implantation in selected TR patients.

Conclusions:

  • Transcatheter approaches for tricuspid regurgitation are emerging with promising early results.
  • Caval valve implantation represents a potential new avenue for treating severe TR.
  • Further research and larger trials are needed to establish the definitive role of caval valve implantation in TR management.